Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

SYSMEX-EUROPA

Sysmex Europe designs and produces laboratory and hematology diagnostic solutions, including instruments, reagents, c... read more Featured Products: More products

Download Mobile App




Next-Generation Models Launched for Sediment Urinalysis Testing

By LabMedica International staff writers
Posted on 05 Oct 2015
Urine sediment analysis is an important test used in diagnosing renal disease and urinary tract disorders and a new model for this analysis has just been launched. More...


Urine testing is divided into urine chemistry, a primary test employing urine test paper, and urine sediment analysis, secondary testing to provide a more detailed analysis of specimens that have been determined to be abnormal during urine chemistry.

Urine sediment analysis is an important test used in diagnosing renal disease and urinary tract disorders. Clinical laboratory technologists use microscopes to observe (microscope testing), classify and measure formed elements in the urine, including red blood cells, white blood cells and bacteria. The ability to perform automated quantitative analysis of formed elements in the urine by using the flow cytometry method was established almost 20 years ago.

Sysmex Corporation (Kobe, Japan) has launched its new products in the sediment urinalysis testing field, the UF-5000/4000/3000 fully automated analyzers of formed elements in urine. The instruments will be rolled out successively on a global scale, beginning with the Japanese market in September 2015. The new models employ blue lasers and other technologies to improve precision and fraction1 and can be used for testing urine and other bodily fluids.

The modular concept is employed to flexibly enable instruments to be added as the number of specimens grows. This concept also allows for future linkage with urine chemistry analyzers and for transport connections among multiple devices at large-scale facilities. Designed to optimize customer usability, the models employ the “Silent Design 3” concept and have simple operating panels. Some RFID4 cassette-type reagents are used to simplify reagent management and replacement.

To contribute to customer operating efficiency, the models are provided in combination with the Urinalysis Work Area Information Management System (U-WAM), which enables urinalysis departments to centrally manage test results. By continuing to provide valuable products in the urinalysis field going forward, Sysmex aims to establish a leading global position in this field of testing.

Related Links:

Sysmex Corporation



Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.